These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 21680672)

  • 21. Detection of immunoglobulin M antibodies to glycoprotein G-2 by western blot (immunoblot) for diagnosis of initial herpes simplex virus type 2 genital infections.
    Ho DW; Field PR; Irving WL; Packham DR; Cunningham AL
    J Clin Microbiol; 1993 Dec; 31(12):3157-64. PubMed ID: 7508453
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serological profile of HSV-2 in patients attending STI clinic: evaluation of diagnostic utility of HSV-2 IgM detection.
    Choudhry S; Ramachandran VG; Das S; Bhattacharya SN; Mogha NS
    Indian J Pathol Microbiol; 2009; 52(3):353-6. PubMed ID: 19679959
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mature glycoprotein g presents high performance in diagnosing herpes simplex virus type 2 infection in sera of different tanzanian cohorts.
    Görander S; Mbwana J; Lyamuya E; Lagergård T; Liljeqvist JA
    Clin Vaccine Immunol; 2006 Jun; 13(6):633-9. PubMed ID: 16760320
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Performance of commercial herpes simplex virus type-2 antibody tests using serum samples from Sub-Saharan Africa: a systematic review and meta-analysis.
    Biraro S; Mayaud P; Morrow RA; Grosskurth H; Weiss HA
    Sex Transm Dis; 2011 Feb; 38(2):140-7. PubMed ID: 20706175
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Performance evaluation of four type-specific commercial assays for detection of herpes simplex virus type 1 antibodies in a Middle East and North Africa population.
    Aldisi RS; Elsidiq MS; Dargham SR; Sahara AS; Al-Absi ES; Nofal MY; Mohammed LI; Abu-Raddad LJ; Nasrallah GK
    J Clin Virol; 2018 Jun; 103():1-7. PubMed ID: 29597097
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Performance of focus ELISA tests for HSV-1 and HSV-2 antibodies among university students with no history of genital herpes.
    Mark HD; Nanda JP; Roberts J; Rompalo A; Melendez JH; Zenilman J
    Sex Transm Dis; 2007 Sep; 34(9):681-5. PubMed ID: 17457239
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of sexually transmitted disease (STD) coinfections on performance of three commercially available immunosorbent assays used for detection of herpes simplex virus type 2-specific antibody in men attending Baltimore, Maryland, STD clinics.
    Summerton J; Riedesel M; Laeyendecker O; Gaydos C; Maldeis NE; Hardick A; Morrow RA; Quinn TC
    Clin Vaccine Immunol; 2007 Dec; 14(12):1545-9. PubMed ID: 17913866
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A monoclonal blocking EIA for herpes simplex virus type 2 antibody: validation for seroepidemiological studies in Africa.
    Gopal R; Gibbs T; Slomka MJ; Whitworth J; Carpenter LM; Vyse A; Brown DW
    J Virol Methods; 2000 Jun; 87(1-2):71-80. PubMed ID: 10856754
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of a fully automated glycoprotein G-2 based assay for the detection of HSV-2 specific IgG antibodies in serum and plasma.
    Groen J; Hersmus B; Niesters HG; Roest W; van Dijk G; van der Meijden W; Osterhaus AD
    J Clin Virol; 1999 May; 12(3):193-200. PubMed ID: 10382816
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inaccuracy of certain commercial enzyme immunoassays in diagnosing genital infections with herpes simplex virus types 1 or 2.
    Morrow RA; Friedrich D
    Am J Clin Pathol; 2003 Dec; 120(6):839-44. PubMed ID: 14671972
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Disclosure of HSV-2 serological test results in the context of an adolescent HIV prevention trial in Kenya.
    Hallfors DD; Cho H; Mbai II; Millimo BW; Atieno C; Okumu D; Luseno WK; Hartman S; Halpern CT; Hobbs MM
    Sex Transm Infect; 2015 Sep; 91(6):395-400. PubMed ID: 26139208
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevalence of herpes simplex virus types 1 and 2 among children and adolescents attending a sexual abuse clinic.
    Ramos S; Lukefahr JL; Morrow RA; Stanberry LR; Rosenthal SL
    Pediatr Infect Dis J; 2006 Oct; 25(10):902-5. PubMed ID: 17006285
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The reliability of serological tests for the diagnosis of genital herpes: a critique.
    Field PR; Ho DW; Irving WL; Isaacs D; Cunningham AL
    Pathology; 1993 Apr; 25(2):175-9. PubMed ID: 8396232
    [TBL] [Abstract][Full Text] [Related]  

  • 34. False-negative type-specific glycoprotein G antibody responses in STI clinic patients with recurrent HSV-1 or HSV-2 DNA positive genital herpes, The Netherlands.
    van Rooijen MS; Roest W; Hansen G; Kwa D; de Vries HJ
    Sex Transm Infect; 2016 Jun; 92(4):257-60. PubMed ID: 26755775
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Novel approach for specific detection of herpes simplex virus type 1 and 2 antibodies and immunoglobulin G and M antibodies.
    Ohana B; Lipson M; Vered N; Srugo I; Ahdut M; Morag A
    Clin Diagn Lab Immunol; 2000 Nov; 7(6):904-8. PubMed ID: 11063496
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Herpes simplex virus type 2 in Brazil: seroepidemiologic survey.
    Da Rosa-Santos OL; Gonçalves Da Silva A; Pereira AC
    Int J Dermatol; 1996 Nov; 35(11):794-6. PubMed ID: 8915732
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Detection of herpes simplex virus type 2-specific immunoglobulin G antibodies in African sera by using recombinant gG2, Western blotting, and gG2 inhibition.
    Hogrefe W; Su X; Song J; Ashley R; Kong L
    J Clin Microbiol; 2002 Oct; 40(10):3635-40. PubMed ID: 12354858
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparative performance of a novel herpes simplex virus type 2-specific enzyme-linked immunosorbent assay using a targeted chain oligopeptide, peptide 55.
    Al-Sulaiman AM; Vallely PJ; Klapper PE
    Clin Vaccine Immunol; 2009 Jun; 16(6):931-4. PubMed ID: 19369475
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of focus HerpesSelect and Kalon HSV-2 gG2 ELISA serological assays to detect herpes simplex virus type 2 antibodies in a South African population.
    Delany-Moretlwe S; Jentsch U; Weiss H; Moyes J; Ashley-Morrow R; Stevens W; Mayaud P
    Sex Transm Infect; 2010 Feb; 86(1):46-50. PubMed ID: 19837726
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Performance of the focus and Kalon enzyme-linked immunosorbent assays for antibodies to herpes simplex virus type 2 glycoprotein G in culture-documented cases of genital herpes.
    Morrow RA; Friedrich D; Krantz E
    J Clin Microbiol; 2003 Nov; 41(11):5212-4. PubMed ID: 14605166
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.